201 related articles for article (PubMed ID: 32295876)
21. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.
Chen YG; Scheuplein F; Driver JP; Hewes AA; Reifsnyder PC; Leiter EH; Serreze DV
J Immunol; 2011 Apr; 186(7):4278-84. PubMed ID: 21357538
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.
Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B
Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858
[TBL] [Abstract][Full Text] [Related]
23. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
24. 4-1BB ligand signaling to T cells limits T cell activation.
Eun SY; Lee SW; Xu Y; Croft M
J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
[TBL] [Abstract][Full Text] [Related]
26. CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages.
Xu Y; Yan Y; Geng T; Wang C; Xu Y; Yang P; Yan J
J Cardiovasc Pharmacol; 2020 Feb; 75(2):148-154. PubMed ID: 31651672
[TBL] [Abstract][Full Text] [Related]
27. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Baessler T; Charton JE; Schmiedel BJ; Grünebach F; Krusch M; Wacker A; Rammensee HG; Salih HR
Blood; 2010 Apr; 115(15):3058-69. PubMed ID: 20008791
[TBL] [Abstract][Full Text] [Related]
28. Analysis of CD137 and CD137L expression in human primary tumor tissues.
Wang Q; Zhang P; Zhang Q; Wang X; Li J; Ma C; Sun W; Zhang L
Croat Med J; 2008 Apr; 49(2):192-200. PubMed ID: 18461674
[TBL] [Abstract][Full Text] [Related]
29. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
[TBL] [Abstract][Full Text] [Related]
30. Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes.
Irie J; Wu Y; Kachapati K; Mittler RS; Ridgway WM
Diabetes; 2007 Jan; 56(1):186-96. PubMed ID: 17192481
[TBL] [Abstract][Full Text] [Related]
31. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
[TBL] [Abstract][Full Text] [Related]
32. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
33. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
34. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor.
Kang SW; Cho HR; Kwon B
Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879
[TBL] [Abstract][Full Text] [Related]
35. Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy.
Itoh A; Ortiz L; Kachapati K; Wu Y; Adams D; Bednar K; Mukherjee S; Chougnet C; Mittler RS; Chen YG; Dolan L; Ridgway WM
Front Immunol; 2019; 10():2566. PubMed ID: 31787971
[TBL] [Abstract][Full Text] [Related]
36. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
38. CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke.
Fann DY; Nickles EP; Poh L; Rajeev V; Selvaraji S; Schwarz H; Arumugam TV
Neuromolecular Med; 2020 Dec; 22(4):474-483. PubMed ID: 33073305
[TBL] [Abstract][Full Text] [Related]
39. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
40. [Impact of CD137-CD137L signaling on secretion of mouse vascular smooth muscle cells-derived exosomes: role of Rab7 pathway].
He Y; Cui XG; Li B; Wang N; Xu Y; Xu Y; Geng TX; Yan JC
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):829-835. PubMed ID: 31648466
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
